<DOC>
	<DOCNO>NCT01210287</DOCNO>
	<brief_summary>The aim study identify incidence hepatitis B virus reactivation rate Diffuse Large B Cell high grade Follicular lymphoma patient prior resolve hepatitis B undergoing RCHOP immuno-chemotherapy .</brief_summary>
	<brief_title>Incidence Hepatitis B Virus ( HBV ) Reactivation HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Reverse Transcriptase Inhibitors</mesh_term>
	<criteria>Naive DLBCL high grade FL patient Age range 1875 year old ECOG performance status 03 Life expectancy 3 month Adequate organ function HBsAg negative/HBcAb positive baseline Infection HAV , HCV , HIV Pregnant lactate woman Serious uncontrolled disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>hepatitis B virus reactivation</keyword>
	<keyword>HBsAg negative</keyword>
	<keyword>HBcAb positive</keyword>
	<keyword>lymphoma</keyword>
	<keyword>rituximab</keyword>
</DOC>